These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9226541)

  • 21. 6-Mercaptopurine in maintaining remission in Crohn's disease: An old friend becomes a new hero.
    Seidman EG
    Gastroenterology; 2000 Oct; 119(4):1158-60. PubMed ID: 11040202
    [No Abstract]   [Full Text] [Related]  

  • 22. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
    Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
    Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
    Hyams JS
    Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
    [No Abstract]   [Full Text] [Related]  

  • 24. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment-associated acute myeloid leukemia in a patient with Crohn's disease on 6-mercaptopurine.
    Das KK; Nishino HT; Chan AT
    Inflamm Bowel Dis; 2010 Sep; 16(9):1454-6. PubMed ID: 20128002
    [No Abstract]   [Full Text] [Related]  

  • 26. Azathioprine and 6 Mercaptopurine in postoperative maintenance of Crohn's disease remission: is no evidence of effect an evidence of no effect?
    Mardini HE
    Gastroenterology; 2005 Jan; 128(1):246-8; author reply 248-9. PubMed ID: 15633153
    [No Abstract]   [Full Text] [Related]  

  • 27. Comment to 'Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease'.
    Yamamoto T; Shiraki M
    Dig Liver Dis; 2013 Mar; 45(3):264. PubMed ID: 22981244
    [No Abstract]   [Full Text] [Related]  

  • 28. 6-mercaptopurine therapy in selected cases of corticosteroid-dependent Crohn's disease.
    Perrault J; Greseth JL; Tremaine WJ
    Mayo Clin Proc; 1991 May; 66(5):480-4. PubMed ID: 1674293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged remission of severe Crohn's disease after fever and leukopenia caused by 6-mercaptopurine.
    Lobel EZ; Korelitz BI; Vakher K; Panagopoulos G
    Dig Dis Sci; 2004 Feb; 49(2):336-8. PubMed ID: 15104380
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
    Jacobstein DA; Baldassano RN
    Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
    [No Abstract]   [Full Text] [Related]  

  • 32. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
    van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
    Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventive therapy in postoperative Crohn's disease.
    Swoger JM; Regueiro M
    Curr Opin Gastroenterol; 2010 Jul; 26(4):337-43. PubMed ID: 20571386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
    Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
    Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine.
    Deutsch DE; Olson AD; Kraker S; Dickinson CJ
    J Pediatr Gastroenterol Nutr; 1995 Apr; 20(3):351-3. PubMed ID: 7608833
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.
    De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits S; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
    Aliment Pharmacol Ther; 2015 Oct; 42(7):867-79. PubMed ID: 26314275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
    Hanai H; Iida T; Takeuchi K; Arai H; Arai O; Abe J; Tanaka T; Maruyama Y; Ikeya K; Sugimoto K; Nakamura T; Nakamura K; Watanabe F
    Dig Liver Dis; 2012 Aug; 44(8):649-54. PubMed ID: 22542605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of azathioprine and 6MP in postoperative Crohn's: changing natural history or just along for the ride?
    Velayos FS; Sandborn WJ
    Am J Gastroenterol; 2009 Aug; 104(8):2097-9. PubMed ID: 19661939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Crohn's disease.
    Greenfield S
    Lancet; 1996 May; 347(9010):1266-7. PubMed ID: 8622485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.